医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Structural basis of the multiple ligand binding mechanisms of the P2X1 receptor

摘要As important modulators of human purinergic signaling,P2X1 receptors form homotrimers to transport calcium,regulating multiple physiological processes,and are long regarded as promising therapeutic targets for male contraception and inflammation.However,the development of drugs that target the P2X1 receptor,such as the antagonist NF449,is greatly hindered by the unclear molecular mechanism of ligand binding modes and receptor activation.Here,we report the structures of the P2X1 receptor in complex with the endogenous agonist ATP or the competitive antagonist NF449.The P2X1 receptor displays distinct conformational features when bound to different types of compounds.Despite coupling to the agonist ATP,the receptor adopts a desensitized conformation that arrests the ions in the transmembrane(TM)domain,aligning with the nature of the high desensitization rates of the P2X1 receptor within the P2X family.Interestingly,the antagonist NF449 not only occupies the orthosteric pocket of ATP but also interacts with the dorsal fin,left flipper,and head domains,suggesting a unique binding mode to perform both orthosteric and allosteric mechanisms of NF449 inhibition.Intriguingly,a novel lipid binding site adjacent to the TM helices and lower body of P2X1,which is critical for receptor activation,is identified.Further functional assay results and structural alignments reveal the high conservation of this lipid binding site in P2X receptors,indicating important modulatory roles upon lipid binding.Taken together,these findings greatly increase our understanding of the ligand binding modes and multiple modulatory mechanisms of the P2X1 receptor and shed light on the further development of P2X1-selective antagonists.

更多
广告
作者单位 School of Pharmacy,Guizhou Medical University,Guizhou 550025,China;Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Zhongshan 528400,China [1] State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China [2] Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Zhongshan 528400,China;School of Pharmaceutical Sciences,Southern Medical University,Guangzhou 510515,China [3] Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Zhongshan 528400,China [4] Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Zhongshan 528400,China;School of Pharmacy,Zunyi Medical University,Zunyi 563006,China [5] Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Zhongshan 528400,China;State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China [6] School of Pharmacy,Guizhou Medical University,Guizhou 550025,China;Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Zhongshan 528400,China;State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;School of Pharmaceutical Sciences,Southern Medical University,Guangzhou 510515,China;School of Pharmacy,Zunyi Medical University,Zunyi 563006,China [7]
栏目名称
DOI 10.1038/s41401-025-01512-y
发布时间 2025-09-28(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览0
  • 下载0
中国药理学报(英文版)

中国药理学报(英文版)

2025年46卷9期

2564-2573页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new智医 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷